Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new study from researchers at Oxford University’s Departments of Zoology and Biochemistry shows that warring bacteria will engage in suicidal attacks in vast numbers to take down competitors.

© Elisa Granato
Illustration shows magenta cells bursting open, committing suicide and releasing toxins to kill the competitor and save their clonemates

Bacteria are aggressive organisms that have evolved a host of draconian ways to kill and inhibit their competitors. One of the most extreme of these strategies is where cells actively break themselves apart and die to release large toxins that kill other strains. While it was known that some bacteria do this, the extent of the behaviour was not known and it was typically assumed that only a few cells would perform these suicidal attacks.

A new study, published today in Current Biology, shows this is far from the case: in some areas of bacterial battlegrounds, almost all cells will kill themselves to generate a massive simultaneous attack.

Suicidal behaviours are very rare in the natural world and it is typically hard to understand why they would evolve. This study reveals that millions of bacteria will simultaneously engage in a suicidal behaviour. Moreover, it shows that this occurs in the best studied of all bacteria: the common gut bacterium, Escherichia coli. This discovery has striking similarities to behaviours seen in social insects, bee and ant

Read more on the University of Oxford website

Similar stories

General anaesthesia should be available for dying patients - medical and ethical experts

General Research

General anaesthesia should be more widely available for patients at the end of their lives, according to Oxford experts in ethics and anaesthesia, according to a paper published by Anaesthesia (a journal of the Association of Anaesthetists).

Human challenge trial launches to study immune response to COVID-19

Clinical Trials Coronavirus COVID-19 General

Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time.

Risk of rare blood clotting higher for COVID-19 than for vaccines

Coronavirus COVID-19 Research

COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.